Immediate and late results of coronary angioplasty in patients with severe left ventricular dysfunction

Federica Marsico1, Emanuela Morenghi, Dennis Zavalloni Parenti

  • 1Invasive Cardiology Department, Istituto Clinico Humanitas, Rozzano, MI, Italy. fmarsico@hotmail.com

Insights

Percutaneous transluminal coronary angioplasty (PTCA) shows high success in treating coronary artery disease with severe left ventricular dysfunction. However, long-term outcomes are not significantly improved by PTCA.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Severe coronary artery disease (CAD) with depressed left ventricular (LV) function indicates a poor prognosis.
  • Percutaneous transluminal coronary angioplasty (PTCA) is an alternative to bypass surgery, but its role in patients with severe LV dysfunction is unclear.

Purpose of the Study:

  • To evaluate the immediate and long-term results of PTCA in patients with severe LV dysfunction (ejection fraction ≤35%).

Main Methods:

  • Analysis of 125 patients with LV ejection fraction ≤35% who underwent PTCA.
  • Assessment of procedural success, complications, and long-term outcomes including restenosis and mortality.

Main Results:

  • Angiographic success was achieved in 96% of patients, with major complications in 4% and a 1.6% mortality rate.
  • Long-term follow-up revealed re-PTCA in 34% due to restenosis and a 10.4% mortality rate.
  • An occluded left anterior descending artery not treated by PTCA or bypass graft was the only predictor of death.

Conclusions:

  • PTCA is effective for CAD in patients with severe LV dysfunction, offering high procedural success and low immediate complications.
  • Long-term follow-up suggests PTCA does not significantly influence overall survival in this patient group.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...